Prothena Corp Public (PRTA) EBT (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly EBT of $32.7 million in Q1 2026, up 251.64% quarter-over-quarter from -$21.6 million in Q4 2025, and up 153.32% on a YoY basis from $12.9 million in Q1 2025.
Prothena Corp Public (PRTA) EBT (2012 - 2026) Analysis & Trends
Prothena Corp Public's EBT history runs 15 years deep, the most recent figure standing at $32.7 million for Q1 2026.
- In Q1 2026, EBT rose 153.32% year-over-year to $32.7 million; the TTM figure through Mar 2026 stood at -$106.7 million (up 7.88% YoY), while the FY2025 annual figure was -$200.8 million, down 55.77% from the prior year.
- EBT was $32.7 million for Q1 2026 at Prothena Corp Public, up from -$21.6 million in the prior quarter.
- In the past five years, EBT ranged from a high of $64.8 million in Q2 2024 to a low of -$81.0 million in Q2 2025.
- Historically, EBT has averaged -$34.3 million across 5 years, with a median of -$48.4 million in 2022.
- The sharpest annual moves came in 2023 and 2024: EBT tumbled 2211.15% in 2023, then soared 210.09% in 2024.
- A 5-year view of EBT shows it stood at $3.3 million in 2022, then sank by 2211.15% to -$70.6 million in 2023, then advanced by 15.74% to -$59.5 million in 2024, then surged by 63.73% to -$21.6 million in 2025, then jumped by 251.64% to $32.7 million in 2026.
- The last three EBT figures came in at $32.7 million (Q1 2026), -$21.6 million (Q4 2025), and -$36.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 32.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.72 Mn |
| Dec 31, 2025 | -21.58 Mn |
| Sep 30, 2025 | -36.91 Mn |
| Jun 30, 2025 | -80.97 Mn |
| Mar 31, 2025 | -61.37 Mn |
| Dec 31, 2024 | -59.50 Mn |
| Sep 30, 2024 | -59.84 Mn |
| Jun 30, 2024 | 64.85 Mn |
| Mar 31, 2024 | -74.44 Mn |
| Dec 31, 2023 | -70.62 Mn |
| Sep 30, 2023 | 18.82 Mn |
| Jun 30, 2023 | -58.90 Mn |
| Mar 31, 2023 | -49.78 Mn |
| Dec 31, 2022 | 3.35 Mn |
| Sep 30, 2022 | -48.42 Mn |
| Jun 30, 2022 | -42.57 Mn |
| Mar 31, 2022 | -37.96 Mn |
| Dec 31, 2021 | -33.10 Mn |
| Sep 30, 2021 | 109.20 Mn |
| Jun 30, 2021 | 27.90 Mn |